Financials
- Market Capitalization 233.57 M
- Employee 106
- Founded 2019
- CEO N/A
- Website www.artivabio.com
- Headquarter Delaware, United States
- FIGI BBG00VPZJ0F9
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.25
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3558 | AVXL Anavex Life Sciences Corp. - Common Stock | 2.43 USD | +3.40% | -7.95% | -4.71% | -78.68% | 225.19 M USD | ||
| 3560 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 9.95 USD | -1.00% | +5.07% | +3.11% | +3.22% | 225.50 M USD | ||
| 3580 | OTLK Outlook Therapeutics, Inc. - Common Stock | 1.69 USD | +9.03% | +19.86% | +28.03% | +309.70% | 204.26 M USD | ||
| 3587 | DTIL Precision BioSciences, Inc. - Common Stock | 8.85 USD | +3.03% | -1.67% | +43.20% | +92.39% | 228.35 M USD |